Charitable Pharmacies of America organization member receives Health Equity grant
Related Posts
The five most recent states to expand the scope of reimbursement for pharmacists are Maryland, Missouri, North Dakota, Virginia and Wyoming
The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, December 2023
Charitable Pharmacies of America organization member receives Health Equity grant
This toolkit, comprised of fact sheets, worksheets, sample communications materials, and sample social media is designed to help aid how you support your own mental health journey, along with your community’s.
Three Healthcare Organizations Join Forces to Save Lives
Starting Sept. 25, Americans can again order free COVID-19 tests through the federal government.
A Fireside Chat with AAM Chair, Christine Baeder and Mark Cuban, Entrepreneur and Cost Plus founder
St. Vincent de Paul Charitable Pharmacy offers article regarding impact of a charitable pharmacy on their community and patients
Branson MO: My Neighbor’s Charitable Pharmacy (NCP) will open its doors at 1232 Branson Hills Parkway February of 2023
The pharmacy industry sees at least five changes
The term digital divide is defined as the differences
of economic and social inequality in both access and usage of ICTs. 2, 3 Some population groups that are
affected by the digital divide include uninsured, at or below 300% of the Federal Poverty Level (FPL), lack
of internet access, etc
How is a charitable pharmacy different from other types of pharmacies?
Today’s release of new 2020 Census data provides population counts of nearly 1,500 race and ethnicity groups and American Indian and Alaska Native (AIAN) tribes and villages.
Federal/state grants are not the only gateways to funding. There are close to 750 “community foundations” nationwide which are public charities dedicated to improving the lives of people in a defined local geographic area.
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

